Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial

Official title:

Patient Satisfaction With Placement of Implantable Venous Access Devices

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01098643
• Other study ID #: CDR0000669012
• Secondary ID: P30CA068485VU-VI
• Status: Terminated
• Phase: N/A
• First received: April 2, 2010
• Last updated: March 30, 2017
• Start date: October 2009
• Est. completion date: September 2011

Study information

• Verified date: March 2010
• Source: Vanderbilt University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

RATIONALE: Gathering information about patients with solid tumors who have implantable venous access devices may help doctors learn more about patient satisfaction.

PURPOSE: This phase I trial is studying satisfaction with placement of implantable venous access devices in patients with solid tumors.

Description:

OBJECTIVES:

• To determine patient satisfaction with subcutaneous venous-access device placement in oncology patients.

OUTLINE: Patients complete a computer-based survey while in the treatment area of the Vanderbilt Oncology Clinic. Basic demographic information and basic information regarding the placement of the device and complications are collected from the patient's medical record.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 88
• Est. completion date: September 2011
• Est. primary completion date: September 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

DISEASE CHARACTERISTICS:

• Diagnosis of a solid tumor malignancy

• No hematological malignancy

• Patient at the Vanderbilt Oncology Clinic

• Has undergone placement of a subcutaneous, single-lumen venous-access device within the past 6 months

• No patients who have had = 2 venous-access devices placed by = 1 department

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics

• Not currently undergoing preparation for or process of stem cell transplantation

Related Conditions & MeSH terms

• Unspecified Adult Solid Tumor, Protocol Specific

Intervention

Other:
• computer-assisted intervention

• medical chart review

• questionnaire administration

• survey administration

Locations

Country	Name	City	State
United States	Vanderbilt-Ingram Cancer Center	Nashville	Tennessee
United States	Vanderbilt-Ingram Cancer Center - Cool Springs	Nashville	Tennessee

Sponsors (2)

Lead Sponsor	Collaborator
Vanderbilt University	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall satisfaction with port placement		n/a - study closed
Secondary	Frequency of complications
Secondary	Frequency of port failure
Secondary	Need for removal of device